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ABSTRACT We report the first evidence of the structure of ,B-amyloid protein as it exists in situ within a slice of human
Alzheimer's diseased brain tissue. Using a Fourier transform infrared microspectroscopic technique, areas of interest can be
selected for spectral measurements with regions of potential contamination masked. In so doing, it is possible to obtain
infrared spectra only of f3-amyloid and not the surrounding grey matter within which it lies. However, to obtain spectra of
high-quality signal-to-noise ratio using a conventional infrared source, we were limited to aperture sizes between 24 ,um x
24 ,um to 50 ,um x 50 ,um. Markedly improved high-quality spectra were acquired with infrared radiation provided by a
synchrotron light source (National Synchrotron Light Source, Brookhaven National Laboratories), using aperture sizes as
small as 12 ,um x 12 ,um. This allowed spectroscopic mapping of brain tissue regions containing amyloid. We observe that
in situ proteins of grey matter exist predominantly in an a-helical and/or unordered conformation, whereas within amyloid
deposits a (3-sheet structure predominates. The hydrogen bonding strength of the (-structure found in situ is different from
that reported in the literature for isolated/chemically synthesized (3-amyloid peptides.
INTRODUCTION
Alzheimer's disease (AD) is the most common form of
dementia, with the clinical symptoms of memory loss, dis-
orientation in person, time and place, and cognitive decline
(McKhann et al., 1984; Katzman and Jackson, 1991). Au-
topsy investigation of the AD brain reveals gross cortical
atrophy, narrow gyri, widened sulci, and enlarged ventricles
(Khachaturian, 1985; Mirra et al., 1993). At the cellular
level, microscopic analysis reveals neuronal loss, synaptic
loss, reactive gliosis, amyloid angiopathy, and the formation
of neurofibrillary tangles and neuritic plaques in the cortical
regions of the brain (Khachaturian, 1985; Mirra et al.,
1993). Neuritic plaques (NPs) exist extracellularly in the
cortex of the AD brain and contain insoluble amyloid (ac-
cummulated aggregated proteins and peptides) deposits sur-
rounded by abnormal neuronal processes (Mirra et al.,
1993). It has been suggested that amyloid deposition is
important (although not necessarily the only key event) in
the pathogenesis of AD (Selkoe, 1994; Sisodia and Price,
1995).
The amyloid of AD brains is composed primarily of
amyloid ,B-peptide (A,3, also known as ,BA4), which is a
4-kDa, 39-43-amino acid peptide derived from the larger
amyloid (3-precursor protein (A(3PP) (Maury, 1995). A,BPP
is expressed throughout the central nervous system, al-
though its role(s) is not well defined. Its ubiquitous presence
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and the high degree of sequence conservation between
species suggest that A(3PP plays an important role(s) in the
biology of neural cells. Abnormal cleavage of A,BPP results
in the accumulation ofAP in the AD brain. AP3's role in any
part of the development ofAD clinical phenotypes, or in the
generation of neuritic plaques, neurofibrillary tangles, and
neuronal death is not yet fully understood. However, in vitro
studies have demonstrated AP to be neurotoxic (Yankner et
al., 1989), and AP3 has been shown to nucleate rapidly into
amyloid fibrils, possibly serving as a seed for the aggrega-
tion and subsequent deposition of amyloid extracellularly
(Jarrett et al., 1993). In addition, A,B may interact with
surrounding proteins such as apolipoprotein E to enhance
the formation of amyloid fibrils (Strittmatter et al., 1993).
In view of the potential role of A,B in AD pathology, there
has been much focus on examining the structure of A13 to
elucidate the structural properties that may dictate the seed-
ing event of fibril formation (Jarrett et al., 1993). An un-
derstanding of the structure-function relationship of this
peptide as it relates to AD pathology may provide insights
for developing new methods of early diagnosis and treat-
ment. Circular dichroism (CD), NMR spectroscopy, x-ray
diffraction, and Fourier transform infrared (FTI) spectros-
copy have been used extensively to study the structure of
A,B (Barrow and Zagorski, 1991; Fraser et al., 1991, 1992,
1993, 1994; Zagorski and Barrow, 1992; Fabian et al., 1993,
1994; Inouye et al., 1993; Otvos et al., 1993). In all of these
studies, either fragments or the whole A,B peptide has been
isolated or chemically synthesized for investigation under a
variety of conditions (extremes of pH, in organic solvents,
etc.). Depending on the solution conditions, synthetic AP3
peptides can adopt mixtures of (3-sheet, ai-helix, and unor-
dered structures. Studies on the 1-42-amino acid j3-amyloid
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peptide in aqueous solution have found that the peptide
adopts a (3-aggregated conformation involving intermolec-
ular hydrogen bonding (Barrow and Zagorski, 1991; Fabian
et al., 1993). It has also been demonstrated that the hydro-
phobic carboxyl terminal sequence, AP3 29-42, adopts an
oligomeric /3-strand structure in solution regardless of dif-
ferences in solvent, pH, and temperature (Barrow and
Zagorski, 1991). On the other hand, the structure of the
N-terminal domain and residues 1-28 varies with the solu-
tion conditions; at pH 1-4 and above pH 7, a monomeric
a-helical structure predominates, whereas between pH 4
and pH 7 the fragment adopts a /3-strand conformation
(Barrow and Zagorski, 1991; Fraser et al., 1991; Zagorski
and Barrow, 1992). However, as many of these studies are
performed on synthetic AP3 and/or fragments of AP3 in
solution, often under nonphysiological conditions (extremes
of pH and temperature, trifluoroethanol solution to solubi-
lize the protein aggregate), one is uncertain whether the
structures reported truly reflect the conformation of A,B as it
exists in the AD brain, particularly given the apparent
sensitivity of the peptide to its environment.
In this study we present results of the first in situ spec-
troscopic study of amyloid in the Alzheimer's diseased
brain, performed on intact slices of AD brain tissue using
Fourier transform infrared (FTIR) microspectroscopy in-
volving IR radiation provided by a synchrotron light source.
This synchrotron-based approach to IR microscopy allowed
very high quality spectra to be obtained at high spatial
resolution (12 ,um X 12 ,um), thus permitting the detection
and analysis of individual neuritic plaques within tissue.
MATERIALS AND METHODS
Human autopsy tissue
Histopathologically confirmed control and Alzheimer's diseased human
autopsy brain tissues were obtained from the Health Sciences Centre
(Winnipeg, MB) and the National Neurological Research Specimen Bank
(Los Angeles, CA). Age-matched control tissue displayed no abnormalities
with respect to cortical atrophy, little presence of neuritic plaques, and the
absence of neurofibrillary tangles upon microscopic examination. There
was no clinical history of cognitive decline or central nervous system
disease and no sign of head trauma. AD tissue was derived from individ-
uals with established long-term dementia who had been in chronic care.
AD brains exhibited severe cortical atrophy of the cerebral hemisphere
with narrowed gyri, widened sulci, and ventricular enlargement. His-
topathological analysis revealed innumerable neuritic plaques, neurofibril-
lary tangles, and cerebral amyloid angiopathy. The magnitude of these
pathological changes led to the diagnosis of definite AD according to the
accepted Khachaturian criteria (1985) and revised criteria by Mirra et al.
(1993).
Infrared spectroscopy
Conventional infrared microspectroscopy
Tissue samples (1 cm3) were excised from formalin (10% v/v formalde-
hyde-buffered solution) fixed brains and flash frozen in liquid nitrogen.
Previous studies in this laboratory have demonstrated that formalin absorp-
tions do not interfere with infrared measurements on thin sections of brain
brain tissue (8 ,um) were obtained using a cryostat. These slices were
thaw-mounted on BaF2 optical windows (13 mm diameter; Wilmad Glass
Co., Buena, NJ) and allowed to air dry. For cryotoming purposes, small
amounts of O.C.T. (Miles, Elkhart, IN) were used to anchor the frozen
tissue (examination of tissue spectra revealed no contaminating IR absorp-
tions from O.C.T.). Tissue sections were viewed with light microscope
objectives to identify areas of interest, and infrared spectra were then
recorded with a Digilab (Bio-Rad Lab., Cambridge, MA) FTS-60 FTIR
microspectrometer containing a conventional thermal infrared light source
and a small-element (0.25 mm2) MCT detector. At each location, the
acquisition of spectra in the region 800-4000 cm- 1 involved collecting 512
interferograms over a 3-min time period. Fourier transformation of the
co-added interferograms yielded spectra with a nominal resolution of 4
cm-'. A spectrum of an area of the BaF2 window containing no tissue was
recorded as the background spectrum. Infrared spectra were recorded using
aperture sizes of 12 ptm X 12 ,um, 24 ,um x 24 ,um, and 50 ,.m X 50 Jim.
Synchrotron infrared microspectroscopy
Tissue specimens were prepared as described above; spectra were acquired
using an IR,us FrIR microspectrometer (Spectra-Tech, Shelton, CT)
equipped with a small-element (0.25 mm2) MCT detector and interfaced to
a synchrotron light source (National Synchrotron Light Source,
Brookhaven National Laboratories, Upton, NY). Again, a spectrum of the
BaF2 window containing no tissue was used as the background. Two
mapping experiments were performed on separate tissue sections. In the
first, a rectangular region 109 ,um X 66 ,um was mapped with an aperture
size of 12 ,um X 12 ,um, with 13-,um steps in the horizontal direction and
14-tLm steps in the vertical direction. For each 12 ,um X 12 ,um region, 512
interferograms were acquired over a 3-min time period, signal averaged,
and Fourier transformed to generate a spectrum with a nominal resolution
of 4 cm- . For the second map, a rectangular region 299 ,um X 208 ,um
was mapped with 27-pm steps in the horizontal direction and 30-pum steps
in the vertical direction. The aperture size was increased to 24 ,um x 24
pum to reduce data acquisition time for this large region. With this larger
aperture size, 128 interferograms were collected over a 2-min time period,
signal averaged, and Fourier transformed to generate spectra with a reso-
lution of 4 cm- All spectra were baseline corrected and Fourier smoothed
using the IRpus software. From the spectra acquired in the mapping exper-
iments, the integrated area under the amide I band was calculated for each
spectrum and plotted as a function of position to produce a three-dimen-
sional surface contour plot. In addition, the corresponding peak frequency
of the amide I band was determined from the inflection point of the first
derivative spectrum and plotted as a function of position to yield a two-
dimensional contour plot.
Histology
The tissue sections from control and diseased brains used to acquire spectra
were stained with Congo red, a dye that specifically stains amyloid deposits
pink-red. Stained tissues were then examined by light microscopy to
confirm the presence and locations of amyloid deposition.
RESULTS AND DISCUSSION
Previous studies from our laboratory have examined con-
trol, multiple sclerosis, and Alzheimer's disease tissues us-
ing conventional FTIR transmission methods (Choo et al.,
1993, 1995). In these studies, we observed that it was not
difficult to differentiate between grey matter and white
matter, based on differences in spectral features arising from
lipids (phospholipids and galactolipids) in white matter. On
the other hand, it was more difficult to distinguish control
tissue (manuscript in preparation). From the frozen sample, thin slices of
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grey matter from AD grey matter; only subtle differences in
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the amide I band were observed. However, these differences
were inconsistent, making it difficult to reach a firm con-
clusion. This inconsistency was most likely due to the
varying density of amyloid deposits between patients and
within tissue sampled from different regions of the same
brain. Furthermore, these microscopic plaques may account
for only a small proportion of the tissue sample, in which
case the characteristic spectroscopic features of the plaque
would be masked by absorptions from the surrounding
grey matter. In addition, with this approach it is difficult
to determine the exact nature of the sample because the
morphology of the tissue is destroyed after pressing
between windows, making analysis by a neuropathologist
impossible.
Conventional infrared microspectroscopy
To improve the chances of observing spectroscopic features
characteristic of amyloid in neuritic plaques in situ, infrared
microspectroscopy was employed. The FTIR microscope
consists of a beam condenser, which focuses the IR radia-
tion onto a small area, thereby allowing investigation of
small samples with high optical throughput. With this tech-
nique, undesirable tissue areas can be masked and specific
areas of interest in the tissue can be investigated. In addi-
tion, the use of a movable stage allows tissue to be mapped
spectroscopically. This technique has been used previously
to examine normal mouse brain tissue in situ (Wetzel and
LeVine, 1993). In addition, Hill et al. have employed the
infrared microsampling technique to study aluminum sili-
cate deposition in the synapse between nerve cells in AD
tissue (Hill et al., 1989).
Spectra recorded from the same location with an infrared
microscope attached to a conventional FTIR spectrometer,
using 12 Am X 12 ,m, 24 ,um X 24 ,um, and 50 ,um X 50
,um aperture sizes, are shown in Fig. 1. The signal-to-noise
ratio of the spectrum acquired with a 12 ,um X 12 ,um
aperture is extremely poor, indicating that only a very small
I0.1 A.U.
FIGURE 1 Representative IR spectra of a 8-,um-
thick slice of AD grey matter recorded at various
aperture sizes with a FrIR microspectrometer equipped
with a conventional thermal light source.
amount of IR light from the source is passing through the
aperture and the tissue to reach the detector. However, if the
aperture is opened to 24 ,um X 24 ,um, there is a marked
improvement in the quality of the spectra, although noise
still persists, making spectral analysis less reliable. At ap-
ertures of 50 ,um x 50 ,um, the spectra are of sufficient
quality for spectroscopic analysis to be performed. With
larger aperture sizes, the number of photons reaching the
detector is increased, thereby improving the spectral quality.
Simultaneously, however, the sampling area is increased
and tissue that may not be of interest, such as the grey
matter surrounding neuritic plaques, will be included in the
measurement. To improve the spectral quality (i.e., to allow
more photons to reach the detector) without increasing the
aperture size, the intensity of the infrared source must be
increased somehow. This may be accomplished by increas-
ing the voltage supplied to conventional sources (resistively
heated ceramic globars). However, this will also result in
the generation of significant amounts of heat, which may
damage the tissue. Therefore, using an infrared microspec-
trometer equipped with a conventional infrared thermal
emission source, the spatial resolution is limited to between
24 ,um x 24 Am and 50 ,um X 50 ,um.
Synchrotron infrared microspectroscopy
To improve spatial resolution without compromising the
signal-to-noise ratio, we recorded spectra using an FTIR
microspectrometer attached to a synchrotron light source.
The intrinsic brilliance of a synchrotron light source is
100-1000 times greater than a traditional thermal emission
source (Reffner et al., 1995). Furthermore, the source is
highly collimated (thus improving spatial resolution) and
nonthermal, thereby eliminating the risk of tissue damage
from excess heat production. In Fig. 2 we present the
spectra of control and Alzheimer's disease tissue recorded
with aperture sizes of 12 ,um X 12 ,um and 24 ,um X 24
Am. The differences between white and grey matter are as
Aperture
size:
50Mm x 50Mm
24Am x 24Mm
l l Afll lal^ 8^&, ~~~~~121Am x 121AM
2000 2400 2800 3200 3600 4000
wavenumber, cm -'
1200 1600
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FIGURE 2 Representative IR spectra of 8-Am-thick slices of control
grey (CG), control white (CG), Alzheimer's diseased grey (AG), and
Alzheimer's diseased white (AW) matter recorded with an FrIR mi-
crospectrometer with IR radiation from a synchrotron light source.
observed in previous studies. As expected, the spectra have
a superior signal-to-noise ratio compared to spectra ob-
tained with a conventional light source (compare with Fig.
1). However, spectra recorded at 12 g~m X 12 g~m show
some deterioration below 1200 cm-', as the instrument's
performance begins to be limited by diffraction properties.
As the wavelength of radiation passing through begins to
approach the aperture size (1000 cm-' = 10 ram), the
radiation is scattered radially upon passing the aperture,
resulting in fewer photons reaching the detector and increas-
ing the noise level at low wavenumbers.
Spectroscopic mapping of AD tissue
Having determined that it is possible to obtain high-quality
spectra of 1260 m X 1220 m or 2400 m X 2430 m regions of
tissue using synchrotron-derived JR radiation, we proceeded
to spectroscopically map AD tissue sections at this spatial
resolution. The region of tissue outlined in Fig. 3 was
chosen for mapping because of the presence of a dense
amorphous deposit that was suspected to be a neuritic
plaque (labeled NP?) within the grey matter (G). Other
morphological features identified in the photomicrograph
(magnified 320X) include part of a cerebral blood vessel
(BV) and cortical neurons (N) that shrank upon freezing!
drying, leaving artefactual spaces (S) or small tears within
the specimen (it should be stressed that these artefacts affect
only the physical integrity, and not the chemical composi-
tion of the sample). From the rectangular region outlined,
spectra were obtained with an aperture size of 12 ,Am), 12
ratm, beginning at (0,0)rdm and progressing in steps of 13
slm in the horizontal direction (eight spectra acquired). The
FIGURE 3 Photomicrograph (320X magnification) of a 8-,um-thick
slice ofAD human grey (G) matter. The tissue contains a suspected neuritic
plaque (NP?), part of a blood vessel (BV), cortical neurons (N), and
artifactual spaces (S). The region mapped spectroscopically is indicated by
the marked rectangle, with coordinates in micrometers.
stage was then moved 14 ,um in the y-direction, and a
further eight spectra were acquired. This process was con-
tinued until the (109,66) ,um position was reached. As we
are primarily interested in studying the structure of amyloid
within neuritic plaques in situ, we specifically examined the
infrared spectra in the region between 1500 and 1700 cm-'
containing strong bands arising from the amide linkage
between amino acid residues. These absorptions, particu-
larly the strong amide I band between 1600 and 1700 cm-1
(carbonyl stretching vibration of the amide group), are sen-
sitive to protein secondary structure (Jackson and Mantsch,
1993, 1995). Fig. 4 A illustrates the three-dimensional sur-
face contour plot of the integrated intensity of the area under
the amide I band for each spectrum corresponding to the
region mapped. The values of the x and y axes are the
positions along the rectangular region in the photomicro-
graph, with the z axis representing the integrated band area.
The low-intensity areas are represented by red, orange, and
yellow, whereas the high-intensity areas are represented by
green and blue. The integrated amide I intensity is fairly
constant in the regions surrounding the deposit. However,
there is a dramatic increase in the intensity of the amide I in
the region of the deposit, with a maximum intensity occur-
ring at the center of the feature, [(55,40) ,um], indicating a
substantial increase in protein concentration at this position.
To further investigate the nature of this protein deposit, a
two-dimensional contour plot of the amide I peak frequency
as a function of the area mapped is shown in Fig. 4 B.
Again, the x and y axes correspond to the mapping coordi-
nates, whereas the contour lines and colors represent the
peak frequencies; red, orange and yellow represent high
frequencies, and blue and green, low frequencies. In the
regions surrounding the deposit, the amide I peak frequency
is 1652-1654 cm-', indicative of proteins predominantly in
an a-helical and/or unordered structure (Jackson and
Mantsch, 1995). However, at the center of the deposit, the
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FIGURE 4 (A) Three-dimensional surface map of the integrated area
under the amide I band corresponding to the rectangular region marked in
Fig. 3. (B) Two-dimensional contour map of the amide I peak frequency of
the region mapped. (C) Enlarged photomicrograph of the tissue of interest
after staining with Congo red for amyloid (reddish-pink).
frequency is shifted to 1632-1634 cm-', indicating the
presence of proteins with a substantially different ((-sheet)
conformation. This trend is illustrated more clearly in Fig. 5,
which illustrates the amide I region from the series of
FIGURE 5 Series of IR spectra, plotted in the amide region, extracted
from a horizontal strip (0,40) ,tm to (104,40) ,um of the region mapped in
Fig. 3.
spectra extracted from a horizontal strip (at about 40 ,um in
the y-position), corresponding to a cross-sectional slice of
the map. With increasing mapping coordinates in the hori-
zontal direction, there is a gradual decrease in intensity of
the 1653 cm-1 absorption with a concomitant increase in
the intensity of the 1631 cm-l band. At a position corre-
sponding to the center of the deposit, the 1631 cm-' band
is the most prominent absorption. This trend is reversed,
moving away from the center to the right edge of the map,
corresponding to the surrounding grey matter. Similar
trends are observed for the amide II band, which decreases
in frequency from 1542 cm- l to 1540 cm- 1 at the center of
the deposit. Our mapping experiment therefore demon-
strates that the amorphous deposit in Fig. 3 is predominantly
proteinaceous (exhibiting a very intense amide I absorption)
and exists in a (3-sheet conformation (amide I and H ab-
sorption at 1632 and 1540 cm- , respectively). These re-
sults strongly suggest that this feature is the amyloid core of
a mature neuritic plaque, a suggestion that was confinmed
when the tissue was stained with Congo red, a dye that
specifically stains amyloid reddish-pink (magnified region
shown in Fig. 4 C).
The finding of an amide I maximum at 1632 cm-,
characteristic of (3-sheet structures, conflicts with previous
IR studies of synthetic amyloid, which demonstrated amide
I maxima at significantly lower frequencies (1620-1628
cm-l), indicative of aggregated peptide (Fraser et al., 1991,
1992, 1994; Otvos et al., 1993; Fabian et al., 1993, 1994).
This discrepancy may be the result of the presence of other
proteins (e.g., the nonfibrillary amyloid-associated proteins
a-1-antichymotrypsin, apolipoprotein E, heparan sulfate
proteoglycan, laminin, and ubiquitin) in the neuritic plaque
(Maury, 1995). In studies of isolated amyloid, upon aggre-
gation, the peptide can form very strong intermolecular
hydrogen bonds because of close alignment of polypeptide
chains, resulting in a low amide I frequency. However, in
(109,40) Am
v)
4)
0
c
0
0.
U
.C_
CL
a
E
(0.40) MAm
1800
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situ, close alignment of amyloid peptide chains may be
prevented by the presence of the other proteins found in the
plaque, resulting in the formation of weaker hydrogen
bonds and the observation of an amide I at a higher fre-
quency. This indicates that the surrounding proteins play
crucial roles in the overall structure of /3-amyloid aggre-
gates in vivo and may therefore potentially influence any
neurotoxic properties of the amyloid deposit. Future struc-
tural studies of /3-amyloid and those aimed at examining the
effect of potential therapeutics in inhibiting ,B-amyloid ag-
gregation should therefore carefully consider the presence
of surrounding proteins, which we suggest affect the overall
structure of the (3-amyloid peptide in situ.
The tissue mapped in the previous section contained a
relatively large plaque that was fairly easy to identify with-
out staining. However, it is generally more difficult to
visually identify areas of amyloid deposition. Fig. 6 is a
photomicrograph (magnified 200X) of another region of
AD cortical grey matter containing shrunken neuronal cells
(N), freezing artifact spaces (S), as well as a cerebral blood
vessel (BV) complete with the vascular wall (W) and eryth-
rocytes (E) found within its lumenal space, but no visible
neuritic plaques. To determine whether IR spectroscopy
could detect the small plaques expected in such tissue, the
region indicated by the 299 ,am by 208 ,um rectangle was
mapped. The surface three-dimensional map of the inte-
grated amide I band is shown in Fig. 7 A. Across the map,
the area of the amide I band is more variable than the
previous specimen. There is a region of low intensity indi-
cated by red and orange at around (50,200) gm. Comparing -'-
it with the photomicrograph (Fig. 6), this corresponds to the
large artifactual space in the tissue (S). There are two major
areas of increased intensity, in the upper left-hand and upper
.~~~~~~~.
e1 ~ ~~~~,1 WRD
-A
4
FIGURE 7 (A) Three-dimensional surface map of the integrated area
under the amide I band corresponding to the rectangular region marked out
in Fig. 6. (B) Two-dimensional contour map of the amide I peak frequency
of the region mapped. (C) Enlarged photomicrograph of the tissue of
interest after staining with Congo red for amyloid (reddish-pink).
FIGURE 6 Photomicrograph (200X magnification) of an 8-gm-thick
slice of human AD grey (G) matter containing several shrunken neuronal right-hand regions of the map, indicated by dark green and
cells (N), freezing artifact spaces (S), and a cerebral blood vessel (BV) bu.Ti lvtditgae md raidctsacomplete with the vascular wall (W) and erythrocytes (E). The regionindate a
mapped spectroscopically is indicated by the marked rectangle with coor- increased protein concentration, possibly due to amyloid
dinates in micrometers. deposition.
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FIGURE 8 Series of spectra plotted in the amide region X
extracted from a horizontal region (0, 0) ,um to (299,0)
Am of the region mapped in Fig. 6. 0
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Examination of the amide I peak frequencies corre-
sponding to these regions (Fig. 7 B) reveals bands at
1632-1634 cm-' indicative of ,B-structures, whereas the
surrounding areas have absorption peaks between 1650
and 1656 cm-1, indicative of a-helical and/or unordered
structure. The series of spectra corresponding to a hori-
zontal strip along the top of the map were extracted and
the amide regions displayed in Fig. 8. The spectrum
indicated by the dotted line arises from the lumenal space
of the blood vessel. In most spectra, the amide I band is
observed at 1654-1656 cm-'. However, for several spec-
tra extracted from the upper right corner of the region
mapped, [(0,200) ,um to (0,270) ,um], the major band is
at 1631 cm-', with a minor shoulder at 1654 cm-'.
Similar low-frequency shifts were observed in the amide
II band. Based upon the findings described for the pre-
vious specimen, the observed intense 1631 cm-' band
suggests that amyloid deposits exist in the upper right
and left corners of the area mapped. It may be suggested
that the 1631 cm- band in spectra of the upper right
corner is attributable to specific components intrinsic to
the blood vessel wall. However, previous infrared micro-
imaging studies of arteries report protein amide I fre-
quencies between 1650 and 1653 cm-' from various
sections of the arterial wall (Kodali et al., 1991). There-
fore, our observations are not due simply to strong com-
ponents of the blood vessel wall, but are most likely due
to amyloid deposition. After staining with Congo red dye,
pink coloration is observed in the upper left region and
around the walls of the blood vessel (Fig. 7 C). These
areas of histologically demonstrated amyloid deposition
correspond exactly to the green/blue colored areas in Fig.
7 B, confirming our spectroscopic observations. Thus we
have successfully demonstrated the deposition of amy-
loid within grey matter (neuritic plaques) and within a
cerebral blood vessel (amyloid angiopathy, the presence
of amyloid within the walls of blood vessels, which can
lead to complications such as cerebral hemorrhage and
infarction; Maury, 1995).
In summary, using FTIR synchrotron microspectroscopy,
we have successfully measured spectra of human control
and Alzheimer's diseased brain tissue with a spatial resolu-
tion as high as 12 ,um X 12 ,um, dimensions that come close
to the size of single cells. To the best of our knowledge, this
is the first study in which regions of grey matter containing
extracellular amyloid deposit in situ and amyloid angiopa-
thy were identified spectroscopically. These observations
were confirmed by standard histological techniques (stain-
ing with Congo red dye).
L.-P. Choo gratefully acknowledges studentship support from the Mani-
toba Health Research Council. We thank the National Synchrotron Light
Source, Brookhaven National Laboratories (Upton, NY), for the beam time
to conduct our experiments, as well as Dr. Gwyn Williams, Dr. Lawrence
Carr, and Dr. Douglas VanCampen for their invaluable help while at
Brookhaven. We also acknowledge tissue sources from the Health Sciences
Centre (Winnipeg, MB), as well as the National Neurological Research
Specimen Bank (Los Angeles, CA). This paper was issued as NRCC
publication no. 34775.
REFERENCES
Barrow, C. J., and M. G. Zagorski. 1991. Solution structures of (3 peptide
and its constituent fragments: relation to amyloid deposition. Science.
253:179-182.
Choo, L.-P., M. Jackson, W. C. Halliday, and H. H. Mantsch. 1993.
Infrared spectroscopic characterisation of multiple sclerosis plaques in
the human central nervous system. Biochim. Biophys. Acta. 1182:
333-337.
Choo et al. In Situ Microspectroscopy of AD f3-Amyloid 1679
Choo, L.-P., J. R. Mansfield, N. Pizzi, R. L. Somorjai, M. Jackson, W. C.
Halliday, and H. H. Mantsch. 1995. Infrared spectra of human central
nervous system tissue: diagnosis of Alzheimer's disease by multivariate
analyses. Biospectroscopy. 1:141-148.
Fabian, H., L.-P. Choo, G. I. Szendrei, M. Jackson, W. C. Halliday, L.
Otv6s, and H. H. Mantsch. 1993. Infrared spectroscopic characterization
of Alzheimer plaques. Appl. Spectrosc. 47:1513-1518.
Fabian, H., G. I. Szendrei, H. H. Mantsch, B. D. Greenberg, and L. L.
Otvos. 1994. Synthetic post-translationally modified human AP3 peptide
exhibits a markedly increased tendency to form (-pleated sheets in vitro.
Eur. J. Biochem. 221:959-964.
Fraser, P. E., L. Levesque, and D. R. McLachlan. 1993. Biochemistry of
Alzheimer disease amyloid plaques. Clin. Biochem. 26:339-349.
Fraser, P. E., D. R. McLachlan, W. K. Surewicz, C. A. Mizzen, A. D.
Snow, J. T. Nguyen, and D. A. Kirschner. 1994. Conformation and
fibrillogenesis of Alzheimer A(3 peptides with selected substitution of
charged residues. J. Mol. Bio. 244:64-73.
Fraser, P. E., J. T. Nguyen, H. Inouye, W. K. Surewicz, D. J. Selkoe, M.
B. Podlisny, and D. A. Kirschner. 1992. Fibril formation by primate,
rodent, and Dutch-hemmoragic analogues of Alzheimer amyloid ,B-pro-
tein. Biochemistry. 31:10716-10723.
Fraser, P. E., J. T. Nguyen, W. K. Surewicz, and D. A. Kirschner. 1991.
pH-dependent structural transitions of Alzheimer amyloid peptides. Bio-
phys. J. 60:1190-1201.
Hill, S. L., K. Krishnan, and J. R. Powell. 1989. Infrared microtransmission
and microreflectance of biological systems. Proc. SPIE. 1145:400-402.
Inouye, H., P. E. Fraser, and D. A. Kirschner. 1993. Structure of ,3-crys-
tallite assemblies formed by Alzheimer (3-amyloid protein analogues:
analysis by x-ray diffraction. Biophys. J. 64:502-519.
Jackson, M., and H. H. Mantsch. 1993. Biomembrane structure from FT-IR
spectroscopy. Spectrochim. Acta Rev. 15:53-69.
Jackson, M., and H. H. Mantsch. 1995. The use and misuse of FTIR
spectroscopy in the determination of protein structure. Crit. Rev. Bio-
chem. Mol. Biol. 30:95-120.
Jarrett, J. T., E. P. Berger, and P. T. Lansbury. 1993. The carboxy terminus
of the 83 amyloid protein is critical for the seeding of amyloid formation:
implications for the pathogenesis of Alzheimer's disease. Biochemistry.
32:4693-4697.
Katzman, R., and J. E. Jackson. 1991. Alzheimer disease: basic and clinical
advances. J. Am. Ger. Soc. 39:516-525.
Khachaturian, Z. S. 1985. Diagnosis of Alzheimer's disease. Arch. Neurol.
42:1097-1105.
Kodali, D. R., D. M. Small, J. Powell, and K. Krishnan. 1991. Infrared
micro-imaging of atherosclerotic arteries. Appl. Spectrosc. 45:
1310-1317.
Maury, C. P. J. 1995. Biology of disease. Molecular pathogenesis of
(3-amyloidosis in Alzheimer's disease and other cerebral amyloidoses.
Lab. Invest. 72:4-16.
McKhann, G., D. Drachman, M. Folstein, R. Katzman, D. Price, and E. M.
Stadlan. 1984. Clinical diagnosis of Alzheimer's disease: report of the
NINCDS-ADRDA work group under the auspices of department of
health and human services task force on Alzheimer's disease. Neurol-
ogy. 34:939-944.
Mirra, S. S., M. N. Hart, and R. D. Terry. 1993. Making the diagnosis of
Alzheimer's disease. Arch. Pathol. Lab. Med. 117:132-144.
Otvos, L., G. I. Szendrei, V. M.-Y. Lee, and H. H. Mantsch. 1993. Human
and rodent Alzheimer ,B-amyloid peptides acquire distinct conformations
in membrane-mimicking solvents. Eur. J. Biochem. 211:249-257.
Reffner, J. A., P. A. Martoglio, and G. P. Williams. 1995. Fourier trans-
form infrared microscopical analysis with synchrotron radiation: the
microscope optics and system performance. Rev. Sci. Instrum. 66:
1298-1302.
Selkoe, D. J. 1994. Alzheimer's disease: a central role for amyloid.
J. Neuropathol. Exp. Neurol. 53:438-447.
Sisodia, S. S., and D. L. Price. 1995. Role of ,3-amyloid protein in
Alzheimer's disease. FASEB J. 9:366-370.
Strittmatter, W. J., A. M. Saunders, D. Schmechel, M. Pericak-Vance, J.
Enghild, G. S. Salvesen, and A. D. Roses. 1993. Apolipoprotein E: high
avidity binding to ,B-amyloid and increased frequency of type 4 allele in
late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:
1977-1981.
Wetzel, D. L., and S. M. LeVine. 1993. In situ FT-IR microspectroscopy
and mapping of normal brain tissue. Spectroscopy. 7:40-45.
Yankner, B. A., L. R. Dawes, S. Fisher, L. Villa-Komaroff, M. L. Oster-
Granite, and R. L. Neve. 1989. Neurotoxicity of a fragment of the
amyloid precursor associated with Alzheimer's disease. Science. 245:
417-420.
Zagorski, M. G., and C. J. Barrow. 1992. NMR studies of amyloid
,3-peptides: proton assignments, secondary structure, and mechanism of
an a-helix (3-sheet conversion for a homologous, 28-residue, N-terminal
fragment. Biochemistry. 31:5621-5631.
